Beyond safety: rethinking concomitant radiotherapy and trastuzumab deruxtecan in metastatic breast cancer — from feasibility to precision practice

Study limitation reported by the research below: “Study design classification as 'Expert Opinion / Viewpoint' is inferred from abstract language; the journal section label is not explicitly stated.”